MYECO GROUP LTD — Director's Dealing 2012

Mar 22, 2012

==> picture [588 x 25] intentionally omitted <==

==> picture [588 x 26] intentionally omitted <==

==> picture [588 x 26] intentionally omitted <==

==> picture [588 x 25] intentionally omitted <==

==> picture [588 x 26] intentionally omitted <==

==> picture [588 x 25] intentionally omitted <==

TO: COMPANY ANNOUNCEMENTS OFFICE ASX LIMITED DATE: 23 March 2012

CHANGE IN DIRECTORS’ INTEREST NOTICE

The Company wishes to announce a change in the interests of Directors following the Right Issue. Appendices 3Y Change of Directors’ Interest Notice follows.

Pat Volpe Chairman

==> picture [595 x 27] intentionally omitted <==

==> picture [595 x 26] intentionally omitted <==

==> picture [595 x 26] intentionally omitted <==

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	CARDIA BIOPLASTICS LIMITED
ABN	89 064 755 237

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Mr Pat Volpe
Date of last notice	12 July 2011

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct and indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Ordinary shares and options (expiring 30 June 2015) held by Vermar Pty Ltd and Growth Tech International Pty Ltd of which Mr Volpe is a Director and a Shareholder.
Date of change	21 March 2012
No. of securities held prior to change	Vermar Pty Ltd 87,000,000 ordinary shares Growth Tech International Pty Ltd 33,333,334 ordinary shares
Class	Ordinary shares and options (expiring 30 June 2015)
Number acquired	Vermar Pty Ltd 21,749,982 ordinary shares 21,749,982 options expiring 30 June 2015 Growth Tech International Pty Ltd 8,333,333 ordinary shares 8,333,333 options expiring 30 June 2015

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number disposed	Nil
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$210,583.21
No. of securities held after change	Vermar Pty Ltd 108,749,982 ordinary shares 21,749,982 options expiring 30 June 2015 Growth Tech International Pty Ltd 41,666,667 ordinary shares 8,333,333 options expiring 30 June 2015
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Rights Issue subscription

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Were the interests in the securities or contracts detailed above traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade to proceed during this period? If prior written clearance was provided, on what date was this provided?

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	CARDIA BIOPLASTICS LIMITED
ABN	89 064 755 237

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Dr Frank Glatz
Date of last notice	12 July 2011

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Ordinary shares and options held by Directors spouse
Date of change	21 March 2012
No. of securities held prior to change	Direct 9,000,000 ordinary shares Indirect 5,952,917 ordinary shares 500,000 options expiring 30 June 2012
Class	Ordinary shares and options (expiring 30 June 2015)
Number acquired	Indirect 1,500,000 ordinary shares 1,490,583 options expiring 30 June 2015
Number disposed	Nil
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$10,500

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change	Direct 9,000,000 ordinary shares Indirect 7,452,917 ordinary shares 500,000 options expiring 30 June 2012 1,490,583 options expiring 30 June 2015
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Rights Issue subscription

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade to proceed during this period?

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

If prior written clearance was provided, on what date was this provided?

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3